Tech Company Financing Transactions
Roka Bioscience Funding Round
On 7/28/2011, Roka Bioscience received $20 million in Series C funding from Gen-Probe, New Enterprise Associates and OrbiMed.
Transaction Overview
Company Name
Announced On
7/28/2011
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series C
Investors
Gen-Probe (Paul Gargan)
New Enterprise Associates (James Barrett)
OrbiMed (Jonathan Silverstein)
TPG Biotech (Fred Cohen)
Proceeds Purpose
We are on track to commercialize our first molecular assay for food safety testing later this year.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
20 Independence Blvd. 4th Floor
Warren, NJ 07059
USA
Warren, NJ 07059
USA
Phone
Website
Email Address
Overview
Roka Bioscience (NASDAQ: ROKA) is dedicated to developing rapid, highly accurate molecular assays and instrument systems for the Food Safety Industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mary Duseau
Chief Financial Officer
Lars Boesgaard
Chief Scientific Officer
Michael Becker
Vice President
Erin Dreyling
VP - Manufacturing
David Patterson
VP - Sales
Kevin Giroux
Browse more venture capital transactions:
Prev: 7/27/2011: TribeHR venture capital transaction
Next: 7/28/2011: Enerkem venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs